IGHE and asthma: Typically, patients with more severe asthma symptoms, higher baseline allergen-specific IgE levels, higher sIgE/T-IgE ratio, or those deemed at higher risk for RIT-related SRs were more likely to be prescribed the combination therapy with omalizumab pretreatment.